Glaxosmithkline Pharmaceuticals Ltd.

Financial

	Glaxosmithkline Phar	Ipca Laboratories	Glenmark Pharma
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	7.8 %	8.3 %	10.3 %
R&D as a % of Total Sales	0.07 %	3.12 %	7.3 %
Financials
5 yr Average ROE	40.73 %	13.55 %	3.99 %
5yr average Equity Multiplier	1.9	1.52	1.78
5yr Average Asset Turnover Ratio	0.94	0.76	0.8
5yr Avg Net Profit Margin	24.91 %	11.88 %	2.85 %
Price to Book	23.77	5.22	6.65
P/E	48.81	46.58	78.05
5yr Avg Cash Conversion Cycle	-107.65 Days	54.3 Days	-150.94 Days
Inventory Days	52.59 Days	102.83 Days	32.28 Days
Days Receivable	22.78 Days	72.68 Days	32.34 Days
Days Payable	144.46 Days	111.38 Days	201.14 Days
5yr Average Interest Coverage Ratio	479.64	50.79	4.25
5yr Avg ROCE	44.44 %	17.31 %	17.54 %
5yr Avg Operating Profit Margin	25.23 %	19.8 %	15.96 %
5 yr average Debt to Equity	0.0	0.17	0.38
5yr CAGR Net Profit	20.96 %	-8.34 %	1.54 %
5yr Average Return on Assets	21.84 %	9.41 %	2.09 %
Shareholdings
Promoter Holding	75.0 %	44.72 %	46.65 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-1.57 %	0.0
Change in Mutual Fund Holding (3 Yrs)	1.11 %	0.2 %	9.74 %

Business

	Glaxosmithkline Phar	Ipca Laboratories	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 API 0 Generics 0 Branded Generics 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Formulations 33.08 Branded Generics 50.39 Glenmark Pharma (Branded generics) 0 Pharmaceutical 0 Active Pharmaceutical Ingredient (API) 16.53 Glenmark generics 0 Vaccines 0	Product Wise Break-Up Generics 0 Branded Generics 0 Branded Generics 60.46 Pharmaceutical 0 API 0 Formulations 39.54 Vaccines 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain 0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 3.27	Therapeutic Area Wise Break-Up - Domestic Anti Malarials 3.0 Cardiac Science 17.0 Cough and colds 4.0 0 Hormones 0 Pain 53.0 Vaccines 0 Urology 5.0 Gastro Intestinal 2.0 Anti-Infective 0 Anti-bacterial 5.0 Respiratory 0 Central Nervous System (CNS) 3.0 Neutraceuticals 1.0 Pain Management 0 Dermatology 6.0 Vitamins / Minerals / Nutrients 0 Others 1.0	-
Location Wise Break-Up	Location Wise Break-Up India 98.65 Rest of the World 1.35 Asia (Excluding India) 0 Australia 0 CIS 0 USA 0 Africa 0 Europe 0 Latin America 0 North America 0	Location Wise Break-Up Rest of the World 0 Australia 3.2 North America 0 Africa 6.72 Latin America 0 USA 21.58 Asia Pacific 5.18 CIS 2.91 India 44.73 Europe 15.68	Location Wise Break-Up Rest of the World 17.56 Australia 0 North America 23.88 Africa 0 Latin America 0 USA 0 Asia (Excluding India) 0 CIS 0 India 38.06 Europe 20.5
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

SIGN UP FOR FREE